These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15954365)

  • 1. [Scleroderma].
    Hasegawa M; Takehara K; Sato S
    Nihon Rinsho; 2005 May; 63 Suppl 5():295-9. PubMed ID: 15954365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and therapy for systemic sclerosis].
    Umehara H; Tanaka M; Masaki Y; Fukushima T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2165-70. PubMed ID: 18044151
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma.
    Leask A
    Cell Signal; 2008 Aug; 20(8):1409-14. PubMed ID: 18296024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokine and fibrotic diseases in the skin].
    Takehara K
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):599-602. PubMed ID: 11210752
    [No Abstract]   [Full Text] [Related]  

  • 5. Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
    Blann AD; Constans J; Carpentier P; Renard M; Satger B; Guérin V; Boisseau MR; Neau-Cransac N; Conri C
    Thromb Res; 2003 Feb; 109(4):203-6. PubMed ID: 12757775
    [No Abstract]   [Full Text] [Related]  

  • 6. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
    Denton CP; Abraham DJ
    Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
    Kallenberg CG
    Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
    [No Abstract]   [Full Text] [Related]  

  • 9. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma.
    Leask A; Denton CP; Abraham DJ
    J Invest Dermatol; 2004 Jan; 122(1):1-6. PubMed ID: 14962082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
    Ihn H
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
    Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
    Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
    Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
    Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.
    Stratton R; Shiwen X; Martini G; Holmes A; Leask A; Haberberger T; Martin GR; Black CM; Abraham D
    J Clin Invest; 2001 Jul; 108(2):241-50. PubMed ID: 11457877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoscleroderma associated with lung cancer: correlation of collagen type I and connective tissue growth factor gene expression.
    Querfeld C; Sollberg S; Huerkamp C; Eckes B; Krieg T
    Br J Dermatol; 2000 Jun; 142(6):1228-33. PubMed ID: 10848753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiologic aspects of systemic sclerosis].
    Gran JT; Molberg Ø; Midtvedt Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2622-3. PubMed ID: 16215604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
    Shi-wen X; Pennington D; Holmes A; Leask A; Bradham D; Beauchamp JR; Fonseca C; du Bois RM; Martin GR; Black CM; Abraham DJ
    Exp Cell Res; 2000 Aug; 259(1):213-24. PubMed ID: 10942593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of anti-topoisomerase I antibody and anti-centromere antibody in diagnosis of collagen diseases].
    Takasaki Y
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1926-31. PubMed ID: 14621581
    [No Abstract]   [Full Text] [Related]  

  • 20. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.
    Leask A; Sa S; Holmes A; Shiwen X; Black CM; Abraham DJ
    Mol Pathol; 2001 Jun; 54(3):180-3. PubMed ID: 11376132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.